E
Erytech Pharma SA
PAR:ERYP
Erytech Pharma SA
PAR:ERYP
Price:
0.801
EUR
0.25%
Market Closed
Market Cap:
€27.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Erytech Pharma SA
PAR:ERYP
|
FR |
|
Look Holdings Inc
TSE:8029
|
JP |
|
K
|
KBC Corporation Ltd
SSE:688598
|
CN |
|
TNG Ltd
ASX:TNG
|
AU |
|
G
|
G G Engineering Ltd
BSE:540614
|
IN |
|
L
|
Longyan Kaolin Clay Co Ltd
SSE:605086
|
CN |
|
N
|
Novavis Group SA
WSE:NVG
|
PL |
|
Demant A/S
CSE:DEMANT
|
DK |
Income Statement
Earnings Waterfall
Erytech Pharma SA
Erytech Pharma SA
Income Statement
Erytech Pharma SA
Erytech Pharma SA
Currency: EUR
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
4
N/A
|
4
+12%
|
7
+59%
|
|
| Operating Income | ||||
| Operating Expenses |
(73)
|
(61)
|
(34)
|
|
| Selling, General & Administrative |
(15)
|
(15)
|
(13)
|
|
| Research & Development |
(53)
|
(40)
|
(16)
|
|
| Depreciation & Amortization |
(5)
|
(5)
|
(5)
|
|
| Other Operating Expenses |
0
|
0
|
(0)
|
|
| Operating Income |
(69)
N/A
|
(57)
+18%
|
(27)
+52%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(1)
|
3
|
4
|
|
| Non-Reccuring Items |
0
|
0
|
24
|
|
| Total Other Income |
(3)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
(73)
N/A
|
(54)
+27%
|
0
N/A
|
|
| Net Income | ||||
| Tax Provision |
(0)
|
(0)
|
(1)
|
|
| Income from Continuing Operations |
(73)
|
(54)
|
(0)
|
|
| Net Income (Common) |
(73)
N/A
|
(54)
+27%
|
(0)
+100%
|
|
| EPS (Diluted) |
-39.87
N/A
|
-22.71
+43%
|
-0.07
+100%
|
|
Switch to:
Switch to:
See Also
Discover More
